Skip to Content

Gentaur Urelumab – Anti-TNFRSF9 / CD137 Antibody

https://www.specificitpharma.com/web/image/product.template/21664/image_1920?unique=9fdcd77
Targets CD137 (4-1BB), a costimulatory molecule on activated T-cells. Urelumab enhances T-cell responses and is ideal for immune activation and cancer immunotherapy research.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 €

1,234,567.00 €

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days